During a major phase III trial, pembrolizumab combined with standard treatment kept cancer at bay for an average of 60 months ...

Penelope Lew was just 27-years-old when she was diagnosed with stage two Hodgkins Lymphoma and has issued a critical warning after she dismissed symptoms.